Newly Synthesized Acetylcholinesterase Inhibitors for Alleviating Alzheimer’s Disease using Solid Lipid Nanoparticles

Publisher： Bentham Science Publishers

E-ISSN： 2212-3903|9|2|111-123

ISSN： 1574-8855

Source： Current Drug Therapy, Vol.9, Iss.2, 2014-06, pp. : 111-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review

By  

Current Drug Therapy, Vol. 6, Iss. 4, 2011-11 ,pp. : 240-250

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer’s Disease

By Ojala Johanna O.   Sutinen Elina M.  

Journal of Clinical Medicine, Vol. 6, Iss. 5, 2017-05 ,pp. : 55-55

MDPI

Access to resources Recommend Favorite

Pharmacologie de la maladie d’Alzheimer : vision du futur: Pharmacology of Alzheimer’s Disease: Where Do We Go from Here?

By Sellal François  

Therapie, Vol. 60, Iss. 2, 2005-01 ,pp. : 89-107

Adis International

Access to resources Recommend Favorite

Disease overview - Alzheimer's disease

By Clark Richard  

Drugs In Context, Vol. 1, Iss. 1, 2005-02 ,pp. : 5-16

CSF Medical Communications Ltd

Access to resources Recommend Favorite

Disease overview - Lipid disorders

By Clark Richard   Yawn Roy  

Drugs in Context (US), Vol. 1, Iss. 1, 2005-04 ,pp. : 5-14

CSF Medical Communications Ltd

Access to resources Recommend Favorite